Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a phase II/III randomized controlled trial to evaluate efficacy of platinum-based
chemotherapy vs conventionally prescribed non-platinum monochemotherapy in patients with
platinum-resistant ovarian cancer